Publicaciones en colaboración con investigadores/as de Hospital de Sabadell (23)

2021

  1. Direct costs of relapses in patients with relapsing-remitting multiple sclerosis

    Neurology Perspectives, Vol. 1, Núm. 3, pp. 160-169

  2. Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents

    Journal of Viral Hepatitis, Vol. 28, Núm. 5, pp. 728-738

2018

  1. Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

    Multiple Sclerosis Journal, Vol. 24, Núm. 14, pp. 1843-1851

  2. Sleep apneas and cardiovascular risk after Sleep Apnea Cardiovascular Endpoints Study (SAVE). What next?

    Archivos de Bronconeumologia, Vol. 54, Núm. 5, pp. 241-242

2017

  1. Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

    European Journal of Cancer, Vol. 75, pp. 73-82

2015

  1. Efficacy of home single-channel nasal pressure for recommending continuous positive airway pressure treatment in sleep apnea

    Sleep, Vol. 38, Núm. 1, pp. 13-21

  2. Maternal and Perinatal Outcomes After Bariatric Surgery: a Spanish Multicenter Study

    Obesity Surgery, Vol. 25, Núm. 3, pp. 436-442

2014

  1. Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis

    Sleep, Vol. 37, Núm. 12, pp. 1953-1961B

  2. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy

    Stroke, Vol. 45, Núm. 4, pp. 1046-1052

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

2010

  1. Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

    Chemotherapy, Vol. 56, Núm. 2, pp. 142-146

1999

  1. Prevalencia de bronquitis crónica, asma y obstrucción al flujo aéreo en una zona urbano-industrial de Cataluña

    Archivos de Bronconeumologia, Vol. 35, Núm. 3, pp. 122-128

1996

  1. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa

    Clinical Infectious Diseases, Vol. 23, Núm. 5, pp. 973-978

  2. Measuring health and health state preferences among critically ill patients

    Intensive Care Medicine, Vol. 22, Núm. 12, pp. 1379-1384

  3. Pain evaluation in elderly patients after orthopaedic surgery under regional anaesthesia

    Pain Clinic, Vol. 9, Núm. 3, pp. 303-309

  4. Pneumonia in intubated patients: Role of respiratory airway care

    American Journal of Respiratory and Critical Care Medicine, Vol. 154, Núm. 1, pp. 111-115

1993

  1. Tendencies of mortality from cardiovascular diseases in Catalonia: 1975-1992

    Medicina clínica, Vol. 101, Núm. 16, pp. 604-608

  2. The Prevalence of pain in hospitalized patients

    Medicina clínica, Vol. 101, Núm. 2, pp. 51-54